Nanospectra Biosciences Inc.
This article was originally published in Start Up
Executive Summary
Nanospectra Biosciences multipurpose Nanoshell platform utilizes a novel class of materials that absorb or scatter light at desired wavelengths. Nanoshells can be used to destroy cancer cells by absorbing thermal energy, for tissue welding, as a drug delivery technology, or as a diagnostic to rapidly detect the presence of antigens in whole blood.
You may also be interested in...
One Small Step for FDA...
FDA is building a knowledge base in nanotechnology and testing its current regulatory procedures. But adapting to the new field could stress the agency's already tight resources and may damage its fragile credibility with the public.
Understanding How To Develop BTK Inhibitors In MS Is Evolving
Having a reversible BTK inhibitor in the multiple sclerosis armamentarium could be the best way to favorably impact the treatment landscape.
Science Matters: Setting The Stage For Using Wearables In Oncology Drug Development
Digital biomarkers using data collected with wearable devices are making their way into clinical trials, largely in cardiovascular, respiratory and rare disease settings around physical activity metrics.